Chlorpheniramine maleate, phenylephrine

FDA Drug Profile — Stonarhini

Drug Details

Generic Name
Chlorpheniramine maleate, phenylephrine
Brand Names
Stonarhini
Application Number
M012
Sponsor
Sato Pharmaceutical Co., Ltd.
NDC Codes
1
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE

Indications and Usage

Uses • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itching of the nose or throat • itchy, watery eyes • nasal congestion • temporarily restores free breathing through the nose

Warnings

​Warnings Do not use in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child's prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product. Ask a doctor before use if child has • heart disease • diabetes • high blood pressure • thyroid disease • glaucoma • a breathing problem such as chronic bronchitis Do not give this product to children who are taking sedatives or tranquilizers, without first consulting the child's doctor. When using this product • do not exceed recommended dosage • may cause excitability especially in children • may cause drowsiness • sedatives and tranquilizers may increase the drowsiness effect Stop use and ask a doctor if • nervousness, dizziness, or sleeplessness occur • symptoms do not improve within 7 days or are accompanied by fever. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.